StonvexLoading…
StonvexStonvexStonvexCore line items from TEL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-27 | Q4 2025 2025-12-26 | Annual 2025 2025-09-26 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $9.41B | $4.67B | $17.26B | $12.51B |
Operating Income | $1.92B | $963.00M | $3.21B | $2.29B |
Net Income | $1.60B | $750.00M | $1.84B | $1.18B |
EPS (Diluted) | $5.42 | $2.53 | $6.16 | $3.93 |
Total Assets | $25.68B | $25.55B | $25.08B | $24.87B |
Total Liabilities | $12.30B | $12.42B | $12.35B | $12.34B |
Cash & Equivalents | $1.11B | $1.25B | $1.25B | $672.00M |
Free Cash Flow OCF − CapEx | $1.28B | $607.00M | $3.20B | $2.05B |
Shares Outstanding | 296.00M | 297.00M | 299.00M | 300.00M |